Publications by authors named "Christoffer Bugge"

Claim this Profile
T
Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy.
Ingrid Engebretsen, Kristina Malene Ødegaard, Sigrun Halvorsen, Christoffer Bugge, Ivar Sønbø Kristiansen

Eur Heart J Qual Care Clin Outcomes· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness Analysis of a Maternal Vaccination Program Against Respiratory Syncytial Virus in Norway.
Susanne Gerda Værnø, Francisco Oteiza, Maren Gillebo, Lise Beier Havdal, David Ngaruiya Mwaura, Christoffer Bugge

Influenza Other Respir Viruses· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-20.
Ingrid Engebretsen, Francisco Oteiza, Elisabeth Floberghagen Birkelund, Signe Marie Brandal, Christoffer Bugge

Eur Heart J Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study.
Johanne Elise Nyen, Anja Ødegård Booth, Øyvind Husby, Christoffer Bugge, Ingrid Engebretsen

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study.
Johanne Elise Nyen, Anja Ødegård Booth, Øyvind Husby, Christoffer Bugge, Ingrid Engebretsen

Front Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg) - a register-based study.
Christoffer Bugge, Ingrid Engebretsen, Ivar Sønbø Kristiansen, Erik Magnus Sæther, Ingrid Lindberg-Schager

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatoid arthritis and the risk of ischaemic stroke after diagnosis of atrial fibrillation: a Norwegian nationwide register study.
Anne M Kerola, Eirik Ikdahl, Ingrid Engebretsen, Christoffer Bugge, Anne Grete Semb

Rheumatology (Oxford)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of migraine medication use in Norway: A nationwide registry-based observational study.
Anker Stubberud, Solveig Borkenhagen, Francisco Oteiza, Aud Nome Dueland, Christoffer Bugge

Cephalalgia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event.
Ingrid Engebretsen, Christoffer Bugge, Henrik Støvring, Einar Husebye, Elise Sverre

Atherosclerosis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology and societal costs of myasthenia gravis in Norway: A non-interventional study using national registry data.
Ingrid Engebretsen, Nils Erik Gilhus, Ivar Sønbø Kristiansen, Erik Magnus Sæther, Ingrid Lindberg-Schager, Christoffer Bugge

Eur J Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative retention and effectiveness of migraine preventive treatments: A nationwide registry-based cohort study.
Marte H Bjørk, Solveig Borkenhagen, Francisco Oteiza, Aud N Dueland, Frank E Sørgaard, Christoffer Bugge

Eur J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs.
Ingrid Engebretsen, John Munkhaugen, Christoffer Bugge, Sigrun Halvorsen, Kristina Malene Ødegaard

Eur Heart J Open· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-related costs should be allocated in a comparable way-benchmarking costs of cancer in Nordic countries 2012-2017.
Paulus Torkki, Riikka-Leena Leskelä, Christoffer Bugge, Johanna Eyrun Torfadottir, Sakari Karjalainen

Acta Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic analysis indicates less strict infection control of COVID-19.
Erik Magnus Sæther, Hanna Isabel Løyland, Christoffer Bugge

Tidsskr Nor Laegeforen· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study.
Christoffer Bugge, Stein Kaasa, Erik Magnus Sæther, Hans Olav Melberg, Ivar Sonbo Kristiansen

BMJ Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Men receive more end-of-life cancer hospital treatment than women: fact or fiction?
Christoffer Bugge, Erik Magnus Saether, Ivar Sønbø Kristiansen

Acta Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Societal cost of cancer in Norway -Results of taking a broader cost perspective.
Christoffer Bugge, Erik Magnus Sæther, Odd Terje Brustugun, Ivar Sønbø Kristiansen

Health Policy· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase- and gender-specific, lifetime, and future costs of cancer: A retrospective population-based registry study.
Christoffer Bugge, Odd Terje Brustugun, Erik Magnus Sæther, Ivar Sønbø Kristiansen

Medicine (Baltimore)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study.
Christoffer Bugge, Erik Magnus Sether, Andreas Pahle, Sigrun Halvorsen, Ivar Sonbo Kristiansen

BJGP Open· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Ivar Sønbø Kristiansen, Christoffer Bugge, Olav Helge Førde

Tidsskr Nor Laegeforen· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Does overdiagnoses contribute to high melanoma numbers?].
Ivar Sønbø Kristiansen, Christoffer Bugge, Olav Helge Førde

Tidsskr Nor Laegeforen· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priority-setting in the patients' last years of life.
Ivar Sønbø Kristiansen, Christoffer Bugge

Tidsskr Nor Laegeforen· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis